HPM often advises companies on matters related to the Consumer Product Safety Commission's (CPSC) regulation of drug product packaging. In particular, HPM counsels companies with regard to the child-resistant packaging requirements for prescription and OTC drugs under the Poison Prevention Packaging Act and its implementing regulations. For other consumer products, HPM also advises companies regarding submission to the CPSC of reports of product hazards pursuant to section 15(b) of the Consumer Product Safety Act and the CPSC's interpretive regulation at 16 C.F.R. Part 1115, and litigation arising from those requirements.
Anne Marie Murphy
Developments in the Law